论文部分内容阅读
目的:观察中医辨证分型结合阿奇霉素治疗小儿支原体肺炎的临床疗效。方法:随机选取2015年1月—2016年1月于我院就诊的支原体肺炎患儿114例,随机均分为观察组(n=57)与对照组(n=57),观察组患儿给予中医辨证分型结合阿奇霉素治疗,对照组患儿则仅给予阿奇霉素治疗,对比两组患儿的临床疗效及血清CRP水平。结果:观察组患儿的临床症状改善情况显著优于对照组(P<0.05),治疗总有效率显著高于对照组(P<0.05),住院时间显著短于对照组(P<0.05),不良反应发生率显著低于对照组(P<0.05)。治疗前,两治疗组患者血清中的CRP水平与正常水平相比均偏高,但两组之间差异不显著;治疗后,两组患者血清中的CRP水平均显著降低,但观察组改善更显著,两组相比P<0.05,有统计学意义。结论:采用中医辨证分型结合阿奇霉素治疗小儿支原体肺炎,能够显著改善患儿的临床症状,促进患儿身体康复,缩短住院时间,减少不良反应发生率情况,临床疗效显著,值得在临床上推广使用。
Objective: To observe the clinical efficacy of traditional Chinese medicine syndrome differentiation combined with azithromycin in the treatment of children with mycoplasma pneumonia. Methods: A total of 114 children with mycoplasma pneumonia who were treated in our hospital from January 2015 to January 2016 were randomly divided into observation group (n = 57) and control group (n = 57) TCM Syndromes combined with azithromycin treatment, control children were only given azithromycin treatment, the clinical efficacy of two groups compared with the level of serum CRP. Results: The improvement of clinical symptoms in observation group was significantly better than that in control group (P <0.05). The total effective rate in treatment group was significantly higher than that in control group (P <0.05), and the hospitalization time was significantly shorter than that in control group (P <0.05) The incidence of adverse reactions was significantly lower than that of the control group (P <0.05). Before treatment, CRP levels in serum of the two treatment groups were higher than the normal level, but there was no significant difference between the two groups; after treatment, serum CRP level decreased significantly in both groups, but the observation group improved more Significantly, the two groups compared P <0.05, statistically significant. Conclusion: Treatment of children with mycoplasma pneumonia by TCM syndrome differentiation and azithromycin can significantly improve children’s clinical symptoms, promote physical rehabilitation, shorten the length of hospital stay and reduce the incidence of adverse reactions, the clinical efficacy is significant, it is worth promoting in clinical use .